| Mrs Carla Suzanne Wells, MD | |
|
4050 Barranca Pkwy Ste 200, Irvine, CA 92604-1723 | |
| (949) 559-1911 | |
| (949) 559-4071 |
| Full Name | Mrs Carla Suzanne Wells |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 4050 Barranca Pkwy Ste 200, Irvine, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184787046 | NPI | - | NPPES |
| 00G802780 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | G80278 (California) | Primary |
| 174400000X | Specialist | G80278 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorialcare Saddleback Medical Center | Laguna hills, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorialcare Medical Foundation | 8729277314 | 382 |
News Archive
Researchers from UC San Francisco and the Chan Zuckerberg Biohub have developed a new approach for COVID-19 testing that detects a distinct pattern of immune gene expression in infected individuals.
The world's smallest flexible microscope is diagnosing some big diseases and allowing physicians to treat patients on the spot. Dr. Michel Kahaleh, associate professor of medicine in the Division of Gastroenterology and Hepatology at the University of Virginia Health System, is the only physician in Virginia currently using probe-based confocal laser endomicroscopy (pCLE).
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's resubmission of the New Drug Application (NDA) for perampanel (E2007), an investigational drug, for the treatment of partial-onset seizures associated with epilepsy.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that it has enrolled the first patient in its European Phase 2 clinical trial evaluating WF10 as a treatment for allergic rhinitis.
InteRNA Technologies B.V. and the Dana-Farber Cancer Institute (Boston, USA) have entered into a research agreement to develop microRNA (miRNA)-based therapeutics for cancer.
› Verified 6 days ago
| Entity Name | Memorialcare Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205167350 PECOS PAC ID: 8729277314 Enrollment ID: O20110113000219 |
News Archive
Researchers from UC San Francisco and the Chan Zuckerberg Biohub have developed a new approach for COVID-19 testing that detects a distinct pattern of immune gene expression in infected individuals.
The world's smallest flexible microscope is diagnosing some big diseases and allowing physicians to treat patients on the spot. Dr. Michel Kahaleh, associate professor of medicine in the Division of Gastroenterology and Hepatology at the University of Virginia Health System, is the only physician in Virginia currently using probe-based confocal laser endomicroscopy (pCLE).
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's resubmission of the New Drug Application (NDA) for perampanel (E2007), an investigational drug, for the treatment of partial-onset seizures associated with epilepsy.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that it has enrolled the first patient in its European Phase 2 clinical trial evaluating WF10 as a treatment for allergic rhinitis.
InteRNA Technologies B.V. and the Dana-Farber Cancer Institute (Boston, USA) have entered into a research agreement to develop microRNA (miRNA)-based therapeutics for cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Carla Suzanne Wells, MD 4050 Barranca Pkwy Ste 200, Irvine, CA 92604-1723 Ph: (949) 559-1911 | Mrs Carla Suzanne Wells, MD 4050 Barranca Pkwy Ste 200, Irvine, CA 92604-1723 Ph: (949) 559-1911 |
News Archive
Researchers from UC San Francisco and the Chan Zuckerberg Biohub have developed a new approach for COVID-19 testing that detects a distinct pattern of immune gene expression in infected individuals.
The world's smallest flexible microscope is diagnosing some big diseases and allowing physicians to treat patients on the spot. Dr. Michel Kahaleh, associate professor of medicine in the Division of Gastroenterology and Hepatology at the University of Virginia Health System, is the only physician in Virginia currently using probe-based confocal laser endomicroscopy (pCLE).
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's resubmission of the New Drug Application (NDA) for perampanel (E2007), an investigational drug, for the treatment of partial-onset seizures associated with epilepsy.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that it has enrolled the first patient in its European Phase 2 clinical trial evaluating WF10 as a treatment for allergic rhinitis.
InteRNA Technologies B.V. and the Dana-Farber Cancer Institute (Boston, USA) have entered into a research agreement to develop microRNA (miRNA)-based therapeutics for cancer.
› Verified 6 days ago
Dr. Tiffany Wong Dote, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6650 Alton Pkwy, Women's Health Services Attn: Maria Vasquez, Irvine, CA 92618 Phone: 714-644-2381 Fax: 949-932-6348 | |
Ms. Maryellen Kathryn Shannon, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6 Hughes, Ste 100, Irvine, CA 92618 Phone: 949-680-1880 Fax: 949-680-1881 | |
Miss Lisa Renee Crane, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4050 Barranca Pkwy Ste 200, Irvine, CA 92604 Phone: 949-559-1911 Fax: 949-559-4071 | |
Pantea Mozayeni, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4050 Barranca Pkwy Ste 200, Irvine, CA 92604 Phone: 949-559-1911 Fax: 949-559-4071 | |
Noah Rodriguez, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6650 Alton Pkwy, Medical Office Building 2, 3rd Floor, Irvine, CA 92618 Phone: 949-932-5685 Fax: 949-932-6393 | |
Dr. James P Lin, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 16300 Sand Canyon Ave, Suite 901, Irvine, CA 92618 Phone: 949-453-8600 Fax: 949-453-8601 | |
Dr. Cecilia Anne Perez, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6650 Alton Pkwy, Mob2 3rd Floor, Irvine, CA 92618 Phone: 949-932-5000 |